14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ALIM ranks #13955 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$4.63 (-5.51%)

Volume: 47k

Closed: Dec 03, 2021

Hollow Logo Score: -3.553

Alimera Sciences Stock Forecast

$4.63 (-5.51%)

Volume: 47k

Closed: Dec 03, 2021

Score Hollow Logo -3.553
Which way will ALIM go? Request
Key Stats
Beta 1.63
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Alimera Sciences stock currently holds an RSI14 at 20 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Alimera Sciences stock price took a fall of -5.51% on Friday
(Updated on Dec 03, 2021)


Sell candidate since 2021-12-01 Loss -7.95%

The Alimera Sciences stock price fell by -5.51% on the last day (Friday, 3rd Dec 2021) from $4.90 to $4.63. and has now fallen 5 days in a row. During the day the stock fluctuated 7.36% from a day low at $4.62 to a day high of $4.96. The price has fallen in 6 of the last 10 days and is down by -16.58% for this period. Volume has increased on the last day by 5 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 47 thousand shares were bought and sold for approximately $218.81 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.35 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 10.69% during the next 3 months and, with a 90% probability hold a price between $4.82 and $7.50 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The Alimera Sciences stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $5.17 and $5.11. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 08, 2021, and so far it has fallen -29.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Alimera Sciences gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

Alimera Sciences finds support from accumulated volume at $4.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.34 between high and low, or 7.36%. For the last week, the stock has had a daily average volatility of 8.86%.

Alimera Sciences is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Alimera Sciences stock A Buy?

The Alimera Sciences stock holds several negative signals and despite the positive trend, we believe Alimera Sciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.553

Predicted Opening Price for Alimera Sciences of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$4.74 $4.63 (Undervalued)
Sell Candidate Upgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 14, 2021 "HC Wainwright" gave "$12.00" rating for ALIM. The price target was set to $4.80+10.1%.

Volatility and Risk
Daily Average Volatility: 8.86 %
Overall Risk: Very High High Medium Low Very Low
Volatility
8.86 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $4.82
Price: $4.63
Support: $4.55

ALIM Insider Trading Show all Trades

INSIDER POWER

30.411

Last 100 transactions
Buy: 717 050 | Sell: 23 579 (Shares)
Date Action Amount Person Type
Nov 30, 2021 Buy 3 255 Parsons Erin Stock Option (Right to Buy)
Nov 05, 2021 Buy 1 400 Eiswirth Richard S Jr Common Stock
Nov 04, 2021 Buy 10 086 Eiswirth Richard S Jr Common Stock
Nov 03, 2021 Buy 6 000 Largent James R Stock Option (Right to Buy)
Nov 03, 2021 Buy 10 000 Largent James R Common Stock
Show all Insider Trades
INSIDER POWER

30.411

Last 100 transactions
Buy: 717 050 | Sell: 23 579 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 5.08 9.65 %
4.95 6.84 %
4.87 5.11 %
Current price: 4.63
Support 4.61 -0.50 %
4.53 -2.23 %
4.40 -5.04 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 5.70 23.11 %
5.67 22.46 %
4.82 4.10 %
Current price 4.63
Support 4.55 -1.73%
4.40 -4.97%
4.36 -5.83%

Click to get the best stock tips daily for free!

About Alimera Sciences

Alimera Sciences Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. The company focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individual... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT